KNSA (Kiniksa Pharmaceuticals) Forvard P/E multiplikatori

Kiniksa Pharmaceuticals Ltd (KNSA) kompaniyasining korporativ logotipi

Kiniksa Pharmaceuticals ommaviy bozorga chiqmasdan, kam uchraydigan immun va yurak-qon tomir patologiyalarini davolash uchun dori vositalarini ishlab chiqishga e'tibor qaratadi. GURU.Markets terminali kompaniyaning forward P/E koeffitsiyentini ko'rsatadi, bunda 47.50 qiymati baholash holatini belgilaydi. Biznes avto-yallig'lanishga qarshi kurashish uchun maqsadli usullarni joriy etib, FDA ning qat'iy nazorati ostida perikardit bilan kasallangan bemorlar uchun yopiq ekotizim yaratmoqda.

Prognoz qilingan narxning foydaga nisbati: Kiniksa (KNSA) 04.07.2022 - 16.11.2026 uchun

Kiniksa Pharmaceuticals kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahliliyoti:kiniksa.com
Kiniksa Pharmaceuticals tovar namunasi

Investorlar kelajakdagi o'sish uchun to'langan premiumni baholash maqsadida joriy bozor kapitalizatsiyasini kutilayotgan sof foyda bilan solishtirib, aktivning uzoq muddatli barqarorligini tekshirmoqdalar. Kiniksa Pharmaceuticals (KNSA) kompaniyasining forward P/E ko'rsatkichini tahlil qilish orqali, bozor kamyob patologiyalarni davolash uchun mo'ljallangan yopiq ekotizimga qanchalik premium berishga tayyorligini aniqlash mumkin, bunda klinikalarga integratsiya barqaror pul oqimini kafolatlaydi va bemorlarning kamayishi risklarini yumshatadi.

Kiniksa Pharmaceuticals (KNSA) raqobatchilari

Prognoz qilingan narxning foydaga nisbati ARGX (Argenx)|BNTX (BioNTech Group) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (Abivax SA)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati admabiologics.com (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|Immunovant Inc (IMVT) - Prognoz qilingan narxning foydaga nisbati|Grifols Biemat (GRFS) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Adaptive Biotechnologies|Prognoz qilingan narxning foydaga nisbati CLDX|Forvard P/E multiplikatori auriniapharma.com|Kelajakdagi narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Prognoz qilingan narx-foyda nisbati|AbCellera Biologics - Forvard P/E multiplikatori|tourmalinebio.com - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Precigen (PGEN) - Kelajakdagi narxning foydaga nisbati|Pharming Group - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Nektar Therapeutics Inc|UPB (Upstream Pharma) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori ZBIO|Forvard P/E multiplikatori immunome.com (IMNM)|Forvard P/E multiplikatori GOSS (gossamerbio.com)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati KalVista Pharma (KALV)|SEPN - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Prognoz qilingan narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Forvard P/E multiplikatori|ATXS (Astria Therapeutics, Inc.) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Kelajakdagi narxning foydaga nisbati engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Kelajakdagi narx-foyda multiplikatori|Aerovate Therapeutics - Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori ACRS|Kyverna Therapeutics, Inc - Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati TLSA|CABA: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Ventyx Bio|Kelajakdagi narxning foydaga nisbati Theratechnologies, Inc.|Prognoz qilingan narx-foyda nisbati Avalo Therapeutics AVTX|Forvard P/E multiplikatori ELDN|AGEN (Agenus, Inc.) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Prognoz qilingan narx-foyda nisbati|ATYR: Prognoz qilingan narxning foydaga nisbati|adagene.com (ADAG) - Prognoz qilingan narxning foydaga nisbati|Ikena Oncology (IMA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Shattuck Labs, Inc.|Kelajakdagi narxning foydaga nisbati equilliumbio.com|Prognoz qilingan narxning foydaga nisbati connectbiopharm.com (CNTB)|Forvard P/E multiplikatori IMUX|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Atara Bio|Kelajakdagi narxning foydaga nisbati InflaRx N.V. IFRX|X4 Pharmaceuticals - Kelajakdagi narxning foydaga nisbati|ACET: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CELU (celularity.com)|INMB: Forvard P/E multiplikatori|BRNS: Kapitalizatsiyaning kelajakdagi foydaga nisbati|KZR (Kezar Life Sciences, Inc.) - Forvard P/E multiplikatori|SAB Biotherapeutics Inc. (SABS) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori AKTX|Kelajakdagi narxning foydaga nisbati ENLV (Enlivex Therapeutics Ltd)|Kelajakdagi narxning foydaga nisbati Q32 Bio Inc. QTTB|GOVX - Prognoz qilingan narxning foydaga nisbati|EDSA - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati iBio|CARM: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati XTLB (XTL Biopharmaceuticals, Ltd.)|Kelajakdagi narxning foydaga nisbati boltbio.com|Forvard P/E multiplikatori HCW Biologics|Forvard P/E multiplikatori APVO|AIM - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori ADTX (Aditxt Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati GRI Bio, Inc. (GRI)|XRTX - Kelajakdagi narxning foydaga nisbati|reshapelifesciences.com (HIND) - Prognoz qilingan narxning foydaga nisbati|REVB: Forvard P/E multiplikatori|Indaptus Therapeutics, Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Scinai|Prognoz qilingan narx-foyda nisbati CalciMedica, Inc. CALI|Kelajakdagi narxning foydaga nisbati Affimed NV (AFMD)|Forvard P/E multiplikatori Allakos Inc (ALLK)|Kelajakdagi narxning foydaga nisbati hookipapharma.com HOOK|Forvard P/E multiplikatori IGM Biosciences, Inc. IGMS|iTeos Pharma - Forvard P/E multiplikatori|OCEA - Forvard P/E multiplikatori|TCBP: Forvard P/E multiplikatori|Third Harmonic Bio - Kelajakdagi narx-foyda multiplikatori